NovaBridge Biosciences Shareholders' Equity
NovaBridge Biosciences (NBP) had Shareholders' Equity of $230.94 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-07
- 2023-12-31: Stockholders' Equity Attributable to Parent 1.72B CNY.
- 2022-12-31: Stockholders' Equity Attributable to Parent 2.91B CNY.
- 2022-06-30: Stockholders' Equity Attributable to Parent 4.02B CNY.
- 2021-12-31: Stockholders' Equity Attributable to Parent 4.56B CNY.
CNY
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-12-31 | 1.72B CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 2.91B CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 4.02B CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 4.56B CNY 20-F · filed 2024-04-30 |
| 2021-06-30 | 5.46B CNY 6-K · filed 2022-11-10 |
| 2020-12-31 | 5.63B CNY 20-F · filed 2024-04-30 |
| 2020-09-30 | 3.74B CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | -2.03B CNY 20-F · filed 2023-05-01 |
| 2019-09-30 | -1.63B CNY 6-K · filed 2021-02-05 |
| 2018-12-31 | -955.10M CNY 20-F · filed 2022-04-29 |
| 2017-12-31 | -299.80M CNY 20-F · filed 2021-04-28 |
| 2016-12-31 | -14.51M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-12-31 | $230.94M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $258.92M 6-K · filed 2025-12-18 | |
| 2025-06-30 | $196.73M 6-K · filed 2025-10-06 | |
| 2024-12-31 | $201.16M 20-F · filed 2026-04-07 | |
| 2024-09-30 | $219.74M 6-K · filed 2025-12-18 | |
| 2024-06-30 | $238.49M 6-K · filed 2025-10-06 | |
| 2023-12-31 | $242.58M 20-F · filed 2026-04-07 | $242.00M 20-F · filed 2024-04-30 |
| 2022-12-31 | $417.81M 20-F · filed 2026-04-07 | $421.90M 20-F · filed 2023-05-01 |
| 2022-06-30 | $599.59M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $715.15M 20-F · filed 2025-04-03 | $715.50M 20-F · filed 2022-04-29 |
| 2020-12-31 | $862.40M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $551.08M 6-K · filed 2021-02-05 | |
| 2019-12-31 | -$292.26M 20-F · filed 2020-04-29 |